Clinical Trials on Ovarian Neoplasm Epithelial Borderline in Canada
Total 1490 results
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian Cancer | Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage IV Borderline Ovarian...Canada
-
University Health Network, TorontoCompletedPlatinum-resistant Epithelial Ovarian CancerCanada
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity CancerCanada
-
Azaya Therapeutics, Inc.UnknownCancer | Ovarian Cancer | Ovarian Epithelial Cancer Recurrent | Malignant Female Reproductive System Neoplasm | Ovarian TumorCanada, United States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Endometrial Carcinoma | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Ovarian Sarcoma | Recurrent Ovarian Epithelial Cancer | Stage IV Endometrial Carcinoma | Ovarian Stromal Cancer | Recurrent Ovarian Germ Cell Tumor and other conditionsCanada
-
University Health Network, TorontoCompleted
-
University Health Network, TorontoCompletedStage IV Ovarian Cancer | Stage III Ovarian CancerCanada
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Stage IV Primary Peritoneal Cavity Cancer | Recurrent Fallopian Tube Cancer | Stage IIIA Fallopian Tube Cancer | Stage IIIB Fallopian Tube Cancer | Stage IIIC Fallopian Tube Cancer and other conditionsCanada
-
CHU de Quebec-Universite LavalThe Cancer Research SocietyCompleted
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaTerminatedEpithelial Ovarian CancerCanada
-
University of British ColumbiaBritish Columbia Cancer AgencyNot yet recruiting
-
University Health Network, TorontoAstraZenecaCompleted
-
Ottawa Hospital Research InstituteCompleted
-
University Health Network, TorontoAstraZenecaCompletedOvarian CancerCanada
-
Ottawa Regional Cancer CentreUnknownOvarian CancerCanada
-
University of British ColumbiaCompleted
-
University of British ColumbiaGenzyme, a Sanofi CompanyTerminatedEpithelial Ovarian CancerCanada, United States
-
Centre de recherche du Centre hospitalier universitaire...Université de SherbrookeRecruiting
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Recurrent Uterine Corpus Carcinoma | Stage III Ovarian Cancer AJCC v6 and v7 | Stage III Uterine Corpus Cancer AJCC v7 | Stage IV Ovarian Cancer AJCC v6 and v7 | Stage IV Uterine Corpus Cancer AJCC v7 | Adult Solid NeoplasmCanada
-
University Health Network, TorontoCompletedMicrosatellite Stable Colorectal Carcinoma | Platinum Resistant Epithelial Ovarian Cancer Type II | Estrogen Receptor Positive and HER2 Negative Breast CancerCanada
-
Sunnybrook Health Sciences CentreGlaxoSmithKlineRecruitingOvarian Cancer | Stage IV Ovarian Cancer | High Grade Ovarian Serous Adenocarcinoma | Stage III Ovarian CancerCanada
-
British Columbia Cancer AgencyUniversity of Victoria; University of Texas Southwestern Medical Center; Van...RecruitingOvarian Cancer | AscitesCanada
-
British Columbia Cancer AgencyCarraressi Foundation OVCARETerminatedOvarian Neoplasms | Ovarian CancerCanada
-
Opna-IO LLCTerminatedEpithelial Ovarian Cancer | Gynecologic NeoplasmsUnited States, Canada
-
EndocyteCompletedOvary CancerCanada, United States
-
Andrea McCartOntario Institute for Cancer ResearchWithdrawn
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)TerminatedMaveropepimut-S (MVP-S) and Low-Dose CPA in Patients With Platinum-Resistant Ovarian Cancer (AVALON)Platinum-resistant Epithelial Ovarian CancerUnited States, Canada, Puerto Rico
-
University Health Network, TorontoTerminated
-
British Columbia Cancer AgencyRecruitingOvarian Cancer | Platinum-resistant Ovarian CancerCanada
-
University of MichiganNational Cancer Institute (NCI)CompletedOvarian Cancer Risk | Risk-reducing Surgery | Fallopian Tube Fimbriae | Ovarian Cortical Inclusion CystsUnited States, Canada
-
University Health Network, TorontoCompletedOvarian Cancer | Steroid Cell Tumor, MalignantCanada
-
Janssen Research & Development, LLCCompletedNeoplasmsUnited States, Spain, Canada, Belgium
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerCanada, United States
-
Grupo Español de Investigación en Cáncer de OvarioAstraZenecaCompletedAdvanced Ovarian CancerSpain
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerCanada
-
Ontario Clinical Oncology Group (OCOG)PfizerCompleted
-
CASI Pharmaceuticals, Inc.CompletedOvarian Cancer | Endometrial CancerCanada
-
Sunesis PharmaceuticalsCompletedEpithelial Ovarian CancerUnited States, Canada
-
CASI Pharmaceuticals, Inc.CompletedOvarian Cancer | Peritoneal Cancer | Fallopian CancerUnited States, Canada
-
University Health Network, TorontoTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Bowel ObstructionCanada
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Uterine Carcinosarcoma | Stage IV Ovarian Epithelial Cancer | Ovarian Sarcoma | Recurrent Uterine Sarcoma | Stage III Uterine Sarcoma | Stage IV Uterine Sarcoma | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian Carcinosarcoma | Female Reproductive... and other conditionsUnited States, Canada
-
University Health Network, TorontoCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerCanada, Spain, Australia, Italy, United Kingdom
-
McGill UniversityMcGill University Health Centre/Research Institute of the McGill University... and other collaboratorsRecruiting
-
University Health Network, TorontoGlaxoSmithKlineRecruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Serous Cancer | High Grade Endometrioid CancerCanada
-
NCIC Clinical Trials GroupCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerCanada, United Kingdom
-
Translational Research in OncologyTerminatedOvarian NeoplasmsUnited States, France, Germany, Israel, Ireland, Spain, Canada, United Kingdom
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)Incyte CorporationActive, not recruitingRecurrent Fallopian Tube Cancer | Recurrent Epithelial Ovarian Cancer | Recurrent Peritoneal CancerUnited States, Canada
-
Nova Scotia Health AuthorityDalhousie UniversityRecruitingOvarian Cancer | Frailty | Exercise | Enhanced Recovery After Surgery | Surgical Complication | Prehabilitation | Treatment OutcomesCanada
-
Canadian Cancer Trials GroupAstraZeneca; Cancer Research Institute, New York City; BioAtla, Inc.RecruitingOvarian CancerUnited States, Canada
-
SanofiRegeneron PharmaceuticalsCompletedNeoplasms | Cancer of the OvaryUnited States, France, Canada, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland